MPM BIOIMPACT LLC
41 holdingsFiling period: 2026-03-31Current AUM: $1.62Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | DBVT | DBV Technologies S A | 5.21M | $108.9M | $70.4M | 4.36% | +4.22M | 2026-03-31 |
| 2 | CGEM | Cullinan Therapeutics, Inc. | 7.65M | $108.7M | $126.2M | 7.81% | -- | 2026-03-31 |
| 3 | AKTS | Aktis Oncology, Inc. | 4.84M | $86.5M | $106.7M | 6.60% | -- | 2026-03-31 |
| 4 | LQDA | Liquidia Corporation | 1.41M | $53.0M | $118.2M | 7.31% | +4.3K | 2026-03-31 |
| 5 | ALMS | Alumis Inc | 2.39M | $52.6M | $67.4M | 4.17% | -15,463 | 2026-03-31 |
| 6 | EWTX | Edgewise Therapeutics Inc | 1.66M | $52.3M | $63.8M | 3.95% | +5.4K | 2026-03-31 |
| 7 | RVMD | Revolution Medicines, Inc. | 506.8K | $49.3M | $95.0M | 5.88% | +1.1K | 2026-03-31 |
| 8 | AGIO | Agios Pharmaceuticals Inc | 1.31M | $44.2M | $39.2M | 2.43% | +2.9K | 2026-03-31 |
| 9 | CORT | Corcept Therapeutics, Inc. | 985.7K | $39.7M | $112.9M | 6.98% | -- | 2026-03-31 |
| 10 | TRVI | Trevi Therapeutics Inc | 3.30M | $39.4M | $60.2M | 3.72% | +11.3K | 2026-03-31 |
| 11 | DNTH | Dianthus Therapeutics Inc | 424.0K | $35.6M | $45.3M | 2.81% | -- | 2026-03-31 |
| 12 | XENE | Xenon Pharmaceuticals Inc | 588.7K | $34.2M | $36.9M | 2.28% | +103.1K | 2026-03-31 |
| 13 | MLTX | MoonLake Immunotherapeutics | 1.81M | $33.8M | $33.4M | 2.07% | -- | 2026-03-31 |
| 14 | TVTX | Travere Therapeutics Inc | 1.13M | $33.7M | $63.3M | 3.92% | -- | 2026-03-31 |
| 15 | EVMN | Evommune Inc | 1.46M | $33.5M | $16.4M | 1.01% | +1.34M | 2026-03-31 |
| 16 | CYTK | Cytokinetics Inc | 500.0K | $33.0M | $38.6M | 2.39% | -- | 2026-03-31 |
| 17 | SNDX | Syndax Pharmaceuticals Inc | 1.34M | $31.3M | $25.5M | 1.58% | +3.0K | 2026-03-31 |
| 18 | CNTX | Context Therapeutics Inc | 10.68M | $28.0M | $6.4M | 0.40% | -- | 2026-03-31 |
| 19 | FBRX | Forte Biosciences, Inc. | 1.00M | $25.9M | $76.7M | 4.74% | -- | 2026-03-31 |
| 20 | PVLA | Palvella Therapeutics Inc | 206.4K | $25.7M | $28.7M | 1.78% | +659 | 2026-03-31 |
| 21 | DYN | Dyne Therapeutics, Inc. | 1.41M | $25.5M | $35.5M | 2.19% | +2.8K | 2026-03-31 |
| 22 | STOK | Stoke Therapeutics Inc | 767.0K | $25.0M | $22.1M | 1.37% | -3,251 | 2026-03-31 |
| 23 | CRVS | Corvus Pharmaceuticals Inc | 1.67M | $24.5M | $22.2M | 1.37% | -1,068,796 | 2026-03-31 |
| 24 | RLAY | Relay Therapeutics Inc. | 2.36M | $23.5M | $44.4M | 2.75% | +127.1K | 2026-03-31 |
| 25 | TARS | Tarsus Pharmaceuticals Inc | 329.8K | $23.1M | $19.5M | 1.20% | +881 | 2026-03-31 |
← Scroll →
Page 1 of 2